Nanjing Pharmaceutical Company Limited’s Net Profit Rose 30.8% in First Quarter of 2022

Nanjing Pharmaceutical Company Limited (南京医药股份有限公司) (600713.SH) reported a net profit of 151.9 million yuan in the first quarter of 2022, up 30.8% year-on-year.

Meanwhile, the company posted 11.7 billion yuan in revenue, up 5.6% year-on-year.

At the end of the reporting period, it had 28.1 billion yuan in total assets and 21.7 billion yuan in total liabilities, with a liability-to-asset ratio of 77.3%.